Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

AJMC
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

July 31st 2025

Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.

PFAS | Image credit: Vodkaz - stock.adobe.com
PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds

July 29th 2025

Diabetes monitoring | Image credit: abidika - stock.adobe.com
SGLT2i-Induced Erythrocytosis Not Linked to Clots in Type 2 Diabetes

July 21st 2025

MRI head brain scan - DedMityay - stock.adobe.com
Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes

July 18th 2025

Doctor examines eye anatomy model using magnifying glass | Image credit: Viktor - stock.adobe.com
Clinical Data Predicts Risk of Progression to Proliferative Diabetic Retinopathy

July 15th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background
Continuing Medical Education
View All
August 3rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 3rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Improved Periconception A1C Linked to Reduction in Adverse Pregnancy Outcomes
January 4th 2021

Improved Periconception A1C Linked to Reduction in Adverse Pregnancy Outcomes

Gianna Melillo
A reduction in glycated hemoglobin (A1C) may result in improved perinatal and maternal outcomes among women with prepregnancy diabetes, according to results of a cohort study published in JAMA Network Open.
Machine Learning Predicts Incidence of Gestational Diabetes
December 30th 2020

Machine Learning Predicts Incidence of Gestational Diabetes

Gianna Melillo
Using advanced machine learning models, researchers in China were able to accurately predict incidence of gestational diabetes among pregnant women during their first trimester.
Top 5 Most-Read Diabetes Articles of 2020
December 23rd 2020

Top 5 Most-Read Diabetes Articles of 2020

Gianna Melillo
Advancements in coverage for diabetes technology and improvement in diabetic retinopathy screening rates appear on this year’s list of most-read diabetes articles.
Review Details Relationship Between Frailty, Diabetes in Older Populations
December 22nd 2020

Review Details Relationship Between Frailty, Diabetes in Older Populations

Gianna Melillo
The identification and assessment of frailty, defined as a state of increased vulnerability to adverse health outcomes resulting from loss of physiological reserve, should become a routine aspect of diabetes care, authors of a systematic review and meta-analysis published in The Lancet Health Longevity argued.
Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD
December 15th 2020

Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD

Gianna Melillo
An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.
Poxel's PXL770 Shows Promise in Patients With NASH, T2D
December 14th 2020

Poxel's PXL770 Shows Promise in Patients With NASH, T2D

Gianna Melillo
Results from a phase 2 trial show PXL770 yielded consistently greater responses in high-risk patients with comorbid nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2D) compared with placebo.
Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions
December 7th 2020

Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions

Gianna Melillo
During a session at the at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts outlined the benefits and limitations of pharmacological, surgical, and lifestyle interventions for pediatric patients with obesity.
Dr Paul Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic
December 4th 2020

Dr Paul Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic

Gianna Melillo
In a session at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts discussed challenges faced by patients with diabetes in the wake of the coronavirus disease 2019 (COVID-19) pandemic and lessons learned from the crisis.
Kentucky Telemedicine Program Increases Diabetic Retinopathy Screening Rates
November 28th 2020

Kentucky Telemedicine Program Increases Diabetic Retinopathy Screening Rates

Gianna Melillo
Large telemedicine diabetic retinopathy screening networks based in federally designated safety-net clinics may be able to increase screening access and compliance among otherwise underscreened populations.
Scale wrapped with measuring tape
November 18th 2020

NDPS Data Show Minor Weight Loss Can Almost Halve T2D Risk

Gianna Melillo
For individuals currently in high-risk glycemic categories, losing 2 to 3 kg (4.5-6.5 lb) in combination with increased physical activity over 2 years nearly halved the risk of developing type 2 diabetes (T2D).
Individual hold heart
November 16th 2020

Most Patients With T2D Classified as "High Risk" for Fatal Heart Attack, Stroke

Gianna Melillo
Half of patients with type 2 diabetes (T2D) exhibit very high cardiovascular risk while the majority are at a high risk of fatal heart attack or stroke, according to new research published in the European Journal of Preventive Cardiology.
Paper cutouts of people of various colors
November 14th 2020

Reducing Racial, Ethnic Disparities in Diabetes Prevalence Requires a Multifaceted Approach

Skylar Jeremias
Lowering the higher rates of diabetes seen among racial and ethnic minorities requires solutions to address all of the major factors that contribute to diabetes prevalence.
Race Impacts DME Treatment Efficacy, Study Finds
November 10th 2020

Race Impacts DME Treatment Efficacy, Study Finds

Gianna Melillo
Black individuals with diabetic macular edema (DME) exhibited a significantly lower likelihood of visual acuity improvement following intravitreal bevacizumab treatment compared with White and Hispanic patients.
Two-Year Data Show Combined Efficacy of GLP-1 RAs, SGLT2s for T2D
November 6th 2020

Two-Year Data Show Combined Efficacy of GLP-1 RAs, SGLT2s for T2D

Gianna Melillo
New data show combining glucagon-like peptide-1 receptor agonist (GLP-1 RA) exenatide plus sodium–glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin remains effective after 2 years for type 2 diabetes (T2D) uncontrolled with metformin.
What We’re Reading: J&J Loses Appeal; Opioid Settlement in the Works; Diabetes Prevention Results Released
November 4th 2020

What We’re Reading: J&J Loses Appeal; Opioid Settlement in the Works; Diabetes Prevention Results Released

AJMC Staff
A decision was upheld that Johnson & Johnson (J&J) must pay a $2.1-billion fine from a 2018 court decision; 3 major drug distributors face up to $18 billion in opioid-related fines; a new diabetes prevention platform may assist in symptom prevention.
Site Logo
November 4th 2020

Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries

John M. Clements, PhD Neli P. Ragina, PhD Jordan Killingsworth, BS Thomas G. Weiss, BS S. Akbar Husain, BS Mariam Zunnu Rain, BS Kellie M. Clark, BS Spandana Alla, BS Michelle G. Jin, BS
Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.
CMS Proposes New Rules for CGM Coverage Among Medicare Beneficiaries
October 29th 2020

CMS Proposes New Rules for CGM Coverage Among Medicare Beneficiaries

Gianna Melillo
This week, CMS proposed changes to the Medicare Durable Medical Equipment Prosthetics, Orthic Devices and Supplies (DMEPOS) coverage and payment policies which would expand Medicare coverage for continuous glucose monitors (CGMs).
Contributor: Modern Medicine Meets House Calls—Caring for the Patient With Diabetes in 2020
October 29th 2020

Contributor: Modern Medicine Meets House Calls—Caring for the Patient With Diabetes in 2020

Deb Schoenthaler, MS
Physicians agree that telehealth leads to better and more consistent patient care for patients and their families and provides many more touchpoints for patients with diabetes—all of which should continue after the pandemic in order to provide these patients with the best care going forward.
Weight Reduction Surgery Associated With Reduced Risk of Second Heart Attack in Obese Patients
October 27th 2020

Weight Reduction Surgery Associated With Reduced Risk of Second Heart Attack in Obese Patients

Gianna Melillo
In severely obese patients with previous myocardial infarction, metabolic surgery was associated with a lower risk of heart attack and new onset heart failure, according to study results published in Circulation.
Greater Green Tea, Coffee Consumption Associated With Lower Mortality Risk in T2D Population
October 22nd 2020

Greater Green Tea, Coffee Consumption Associated With Lower Mortality Risk in T2D Population

Gianna Melillo
Consuming more green tea and coffee was associated with reduced all-cause mortality among individuals with type 2 diabetes (T2D), according to the results of a prospective study published in BMJ Open Diabetes Research and Care.
Survey Highlights Challenges of Diabetes Management, Potential Impact of Technology
October 19th 2020

Survey Highlights Challenges of Diabetes Management, Potential Impact of Technology

Gianna Melillo
Results from a national survey conducted by the Association of Diabetes Care & Education Specialists show that individuals living with diabetes feel they are doing everything they can to manage the condition, yet believe more can be done.
Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks
October 15th 2020

Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks

Gianna Melillo
New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.
Can an HIV Drug Help Prevent Diabetes?
October 12th 2020

Can an HIV Drug Help Prevent Diabetes?

Gianna Melillo
Patients who received anti-inflammasome nucleoside reverse-transcriptase inhibitors (NRTIs)—drugs approved to treat HIV-1 and hepatitis B infections—exhibited a 33% reduced risk of developing type 2 diabetes (T2D), according to a meta-analysis published in Nature Communications.
What We’re Reading: Nobel Prize in Chemistry Awarded; Improving Diabetes Management; COVID-19 Vaccine Trial Still on Hold
October 7th 2020

What We’re Reading: Nobel Prize in Chemistry Awarded; Improving Diabetes Management; COVID-19 Vaccine Trial Still on Hold

AJMC Staff
Two women are awarded the Nobel Prize in Chemistry for CRISPR; Eli Lilly partners with DexCom, Inc; the US arm of AstraZeneca’s coronavirus disease 2019 (COVID-19) vaccine trial remains halted.
Study Highlights Persistent Racial Disparities in Insulin Pump Use Among Children With T1D
October 6th 2020

Study Highlights Persistent Racial Disparities in Insulin Pump Use Among Children With T1D

Gianna Melillo
Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted over the past 15 years, independent of socioeconomic status.
NIH Funds First Network to Study Rare Forms of Diabetes
October 5th 2020

NIH Funds First Network to Study Rare Forms of Diabetes

Gianna Melillo
The National Insistutes of Health (NIH) study aims to discover new forms of diabetes, understand what makes them unique, and identify root causes.
Diabetes Drug May Hold Potential as COVID-19 Treatment
September 29th 2020

Diabetes Drug May Hold Potential as COVID-19 Treatment

Gianna Melillo
In patients with type 2 diabetes admitted to the hospital for coronavirus disease 2019 (COVID-19), treatment with sitagliptin at the time of hospitalization was associated with reduced mortality and improved clinical outcomes compared with standard-of-care treatment.
Progress Made in Diabetes Technology Coverage, Access Among Medicare Beneficiaries
September 28th 2020

Progress Made in Diabetes Technology Coverage, Access Among Medicare Beneficiaries

Gianna Melillo
Recently, 2 district courts secured a pair of victories for Medicare beneficiaries who use continuous glucose monitor technologies to manage their diabetes, while senators introduced bipartisan legislation aimed at increasing access to the Medicare Diabetes Prevention Program.
Ertugliflozin CV Outcomes in T2D Population Are Similar to Placebo
September 23rd 2020

Ertugliflozin CV Outcomes in T2D Population Are Similar to Placebo

Gianna Melillo
In patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease, results from a multicenter, double-blind trial show that treatment with ertugliflozin is noninferior to placebo with respect to major adverse cardiovascular events.
Phase 2 Trial Shows Weekly Insulin Injection Outcomes Similar to Daily Injections for T2D
September 22nd 2020

Phase 2 Trial Shows Weekly Insulin Injection Outcomes Similar to Daily Injections for T2D

Gianna Melillo
In individuals with type 2 diabetes with no previous insulin treatment, once-weekly injections of insulin icodec resulted in glucose-lowering efficacy and a safety profile similar to individuals who took once-daily insulin glargine U100.
<1
...
101112131415161718
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo